Tata Power is expected to report a 14.7 percent YoY increase in revenue at Rs 17,457 crore in Q1FY25, as per the average estimates of five brokerage firms.
Marico is expected to witness gradual uptick in demand led by domestic volume growth in the upcoming quarters.
The most optimistic estimate sees Bharti Airtel's net profit jumping 114 percent YoY and the most pessimistic projection suggests that net profit will increase 36 percent on a YoY basis.
Growth expectations for the CDMO player span a vast range as the most optimistic brokerages are predicting as much as 61 percent on year growth while the most pessimistic are baking in forecasts of just 10 percent increase.
The company's SUV segment trails Maruti and M&M, and guidance on the growth will also be essential for the company in the coming quarters.
Sun Pharma's performance in the US market will be driven by ramp-up of Revlimid, resumption of supplies from Mohali unit and growth in its specialty portfolio. Back home, its robust foothold in the chronic segment promises to fuel double-digit growth.
Titan is expected to see a tepid quarter amid lower number of wedding days, rising gold prices and increasing competition from regional players.
Amid the harsh summer, out-of-consumption will be impacted, where Britannia will have a volume impact. However, price cuts are expected to buoy volumes.
During the quarter, the company will likely outperform Tata Motors (3rd largest) for a fifth consecutive quarter.
Maruti Suzuki sold 5.22 lakh vehicles during April-June, an increase of 5 percent on-year. This growth was led by higher sales of the SUV segment and exports.
For the quarter ended June, Dabur India is likely to report revenue at Rs 3,286 crore, rising five percent on-year.
For the three months ended June, ITC is likely to report revenue at Rs 17,171 crore, rising 8.5 percent on-year.
According to a Moneycontrol poll of six brokerages, Tata Consumer is likely to report revenue at Rs 4,293 crore, surging 14 percent on-year
According to a Moneycontrol poll, Ramco Cements' net profit is expected to slump 51 percent on-year to Rs 38 crore in Q1FY25. Revenue is seen falling around 1.3 percent YoY to Rs 2,221 crore.
Analysts will focus on Dr Reddy's R&D expense and margin guidance for FY25.
Cipla's US sales are expected to remain on a strong footing in Q1, but a restructuring of the domestic trade generics business is expected to negatively impact revenue, potentially slowing the drugmaker's growth momentum.
Larsen and Toubro (L&T) is expected to report a 15% YoY increase in net profit to Rs 2,876 crore and a 9.6% YoY rise in revenue to Rs 52,518 crore for Q1FY25.
Volume for the reporting period increased 6.2 percent YoY to 7.4 million tons
According to the average of nine estimates compiled by Moneycontrol, Wipro's consolidated net profit for the quarter ended June is expected to rise over 4 percent QoQ to Rs 2,953 crore, while revenue from operations is likely to remain flat.
UltraTech Cement is set to present its earnings report for Q1 FY25 on July 19, with expectations of subpar performance due to weak prices and declining average realisations despite rising volumes.
Investors will closely watch LTIMindtree management's commentary on performance and outlook across various verticals (BFSI, Hi-Tech, and manufacturing), the deal pipeline, and margin outlook.
BNP Paribas expects an expansion in Infosys EBIT margin in Q1, supported by the reversal of one-off impacts but slightly offset by deal ramp-up costs.
Net Sales are expected to increase by 10.8 percent Y-o-Y (up 3.7 percent Q-o-Q) to Rs. 18,478.5 crore, according to Prabhudas Lilladher.
Net Sales are expected to increase by 11.2 percent Y-o-Y (down 3.5 percent Q-o-Q) to Rs. 1,114.2 crore, according to Prabhudas Lilladher.
Net Sales are expected to increase by 19.2 percent Y-o-Y (down 19.1 percent Q-o-Q) to Rs. 264.9 crore, according to Prabhudas Lilladher.